| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.084 | 0.1 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |